Omeros Corp (OMER) stock is tumbling on Friday morning following a major regulatory setback in Europe that has caught investors off guard. Investors are bailing on OMER mostly because the European Medicines Agency’s (EMA) expert panel has rejected its primary commercial asset. At the time of writing, Omeros stock is down some 50% versus the
Moderna Inc. (MRNA) shares surged nearly 10% on Friday, extending a powerful rally that has lifted the stock about 40% over the past month and significantly outperformed the broader market. The gains followed the company’s Science Day presentation and investor event, where Moderna outlined an ambitious strategy to expand beyond its COVID-19 vaccine business and
Ripple has reported a sharp increase in tokenised assets issued on the XRP Ledger, highlighting growing institutional interest in blockchain-based financial products even as XRP continues to face pressure in the broader cryptocurrency market. The value of tokenised real-world assets (RWAs) on the XRP Ledger rose from about $5 million at the start of 2025
Apple Inc. (AAPL) shares have come under pressure after the company raised prices on several MacBook and iPad models. But some Wall Street analysts believe the pullback could present a buying opportunity as the company leverages its pricing power and loyal customer base. Apple stock fell 6.1% on Thursday after the company announced price increases
The Dow Jones Industrial Average and the broader US stock market closed lower on Friday as investors continued rotating out of technology and semiconductor stocks while shifting into more defensive sectors such as healthcare, consumer staples, and utilities. The S&P 500 slipped 0.27% to close at 7,337.68, while the Nasdaq Composite fell 0.48% to 25,236.88.
The artificial intelligence boom has long been pitched as a transformative force that would boost productivity and eventually lower costs across the economy. But this week, investors were confronted with a less discussed consequence of the AI race: higher prices. Apple and Microsoft both announced product price increases on Thursday, citing soaring costs for memory
A growing chorus of China’s most influential hedge fund managers is sounding the alarm on what they describe as a dangerously overheated global AI trade. After an explosive run-up in semiconductor and model‑development stocks from Seoul to Silicon Valley, several of Beijing’s money managers now argue the rally has detached from fundamentals – and that
US stocks opened higher on Thursday, led by gains in technology shares as strong earnings updates from Micron Technology and Qualcomm reignited optimism around artificial intelligence demand. The Dow Jones Industrial Average was up 270 points or 0.52%. The S&P 500 and the Nasdaq Composite climbed 0.60%. Micron surged 19% in trading after reporting fiscal
Cathie Wood’s Ark Innovation Fund (ARKK) ETF stock has remained inside a narrow range in the past few months. ARKK has remained between the support and resistance levels at $72.68 and $82.35 since April. It has risen by 9% in the last 12 months, while the Nasdaq 100 Index has soared by 28%. ARKK has
US inflation accelerated further in May, with a key measure of price pressures climbing above 4% for the first time in more than three years as higher energy prices stemming from the Middle East conflict filtered through the economy. The Commerce Department’s Bureau of Economic Analysis said on Thursday that the personal consumption expenditures (PCE)